Literature DB >> 26337434

Antimicrobial efficacy of preoperative skin antisepsis and clonal relationship to postantiseptic skin-and-wound flora in patients undergoing clean orthopedic surgery.

G Daeschlein1, M Napp2, F Layer3, S von Podewils4, H Haase4, R Spitzmueller2, O Assadian5, R Kasch6, G Werner3, M Jünger4, P Hinz2, A Ekkernkamp2.   

Abstract

Nosocomial surgical site infections (SSI) are still important complications in surgery. The underlying mechanisms are not fully understood. The aim of this study was to elucidate the possible role of skin flora surviving preoperative antisepsis as a possible cause of SSI. We conducted a two-phase prospective clinical trial in patients undergoing clean orthopedic surgery at a university trauma center in northern Germany. Quantitative swab samples were taken from pre- and postantiseptic skin and, additionally, from the wound base, wound margin, and the suture of 137 patients. Seventy-four patients during phase I and 63 during phase II were investigated. Microbial growth, species spectrum, and antibiotic susceptibility were analyzed. In phase two, the clonal relationship of strains was additionally analyzed. 18.0 % of the swab samples were positive for bacterial growth in the wound base, 24.5 % in the margin, and 27.3 % in the suture. Only 65.5 % of patients showed a 100 % reduction of the skin flora after antisepsis. The microbial spectrum in all postantiseptic samples was dominated by coagulase-negative staphylococci (CoNS). Clonally related staphylococci were detected in ten patients [nine CoNS, one methicillin-susceptible Staphylococcus aureus (MSSA)]. Six of ten patients were suspected of having transmitted identical clones from skin flora into the wound. Ethanol-based antisepsis results in unexpected high levels of skin flora, which can be transmitted into the wound during surgery causing yet unexplained SSI. Keeping with the concept of zero tolerance, further studies are needed in order to understand the origin of this flora to allow further reduction of SSI.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26337434     DOI: 10.1007/s10096-015-2478-7

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  25 in total

1.  Recommended practices for skin preparation of patients.

Authors: 
Journal:  AORN J       Date:  2002-01       Impact factor: 0.676

2.  Typing of methicillin-resistant Staphylococcus aureus in a university hospital setting by using novel software for spa repeat determination and database management.

Authors:  Dag Harmsen; Heike Claus; Wolfgang Witte; Jörg Rothgänger; Hermann Claus; Doris Turnwald; Ulrich Vogel
Journal:  J Clin Microbiol       Date:  2003-12       Impact factor: 5.948

3.  Evaluation of an innovative antimicrobial surgical glove technology to reduce the risk of microbial passage following intraoperative perforation.

Authors:  Georg Daeschlein; Axel Kramer; Andreas Arnold; Andrea Ladwig; Gary R Seabrook; Charles E Edmiston
Journal:  Am J Infect Control       Date:  2011-03       Impact factor: 2.918

Review 4.  Guideline for use of topical antimicrobial agents.

Authors:  E Larson
Journal:  Am J Infect Control       Date:  1988-12       Impact factor: 2.918

5.  Molecular characterisation of methicillin-susceptible and methicillin-resistant Staphylococcus aureus in inpatients and outpatients in Bosnia and Herzegovina.

Authors:  Selma Uzunović-Kamberović; Michelle I A Rijnders; Ellen E Stobberingh; Amir Ibrahimagić; Farah Kamberović; Tatjana Ille
Journal:  Wien Med Wochenschr       Date:  2012-10-10

6.  Efficacy of surgical preparation solutions in foot and ankle surgery.

Authors:  Roger V Ostrander; Michael J Botte; Michael E Brage
Journal:  J Bone Joint Surg Am       Date:  2005-05       Impact factor: 5.284

7.  Dispersal of methicillin-resistant Staphylococcus epidermidis by staff in an operating suite for thoracic and cardiovascular surgery: relation to skin carriage and clothing.

Authors:  A Tammelin; P Domicel; A Hambraeus; E Ståhle
Journal:  J Hosp Infect       Date:  2000-02       Impact factor: 3.926

8.  Effects of preoperative skin preparation on postoperative wound infection rates: a prospective study of 3 skin preparation protocols.

Authors:  Brian R Swenson; Traci L Hedrick; Rosemarie Metzger; Hugo Bonatti; Timothy L Pruett; Robert G Sawyer
Journal:  Infect Control Hosp Epidemiol       Date:  2009-10       Impact factor: 3.254

9.  Alcohol-based handrub: evaluation of technique and microbiological efficacy with international infection control professionals.

Authors:  Andreas E Widmer; Marc Dangel
Journal:  Infect Control Hosp Epidemiol       Date:  2004-03       Impact factor: 3.254

Review 10.  Prosthetic joint infection.

Authors:  Aaron J Tande; Robin Patel
Journal:  Clin Microbiol Rev       Date:  2014-04       Impact factor: 26.132

View more
  3 in total

1.  Comparison of the antimicrobial efficacy of povidone-iodine-alcohol versus chlorhexidine-alcohol for surgical skin preparation on the aerobic and anaerobic skin flora of the shoulder region.

Authors:  Dorothea Dörfel; Matthias Maiwald; Georg Daeschlein; Gerald Müller; Robert Hudek; Ojan Assadian; Günter Kampf; Thomas Kohlmann; Julian Camill Harnoss; Axel Kramer
Journal:  Antimicrob Resist Infect Control       Date:  2021-01-22       Impact factor: 4.887

2.  Cutibacterium avidum resists surgical skin antisepsis in the groin-a potential risk factor for periprosthetic joint infection: a quality control study.

Authors:  Steven M Maurer; Laura Kursawe; Stefan Rahm; Julia Prinz; Annelies S Zinkernagel; Annette Moter; Stefan P Kuster; Reinhard Zbinden; Patrick O Zingg; Yvonne Achermann
Journal:  Antimicrob Resist Infect Control       Date:  2021-02-01       Impact factor: 4.887

3.  Meta-analysis of the efficacy of preoperative skin preparation with alcoholic chlorhexidine compared to povidone iodine in orthopedic surgery.

Authors:  Mario Mastrocola; Georg Matziolis; Sabrina Böhle; Chris Lindemann; Peter Schlattmann; Henk Eijer
Journal:  Sci Rep       Date:  2021-09-20       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.